Beverly Green, MD, MPH, is a physician scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow through with — and easier for providers to deliver.
Dr. Green’s research has a strong public health emphasis, targeting conditions that impact large proportions of the population — such as cardiovascular disease, cancer, and obesity — with an emphasis on leveraging technologies and systems-based care.
In 2022, Dr. Green published the results of the BP-CHECK study, which compared the accuracy and acceptability of ways to diagnose high blood pressure. With a $2.8 million award from PCORI (the Patient-Centered Outcomes Research Institute), the study compared blood pressures taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension. Blood pressures taken at home were the most accurate and most preferred method for diagnosing hypertension. She is working with Kaiser Permanente Washington on their efforts to integrate home blood pressure monitoring into clinical care.
Dr. Green also co-led a National Cancer Institute study that evaluated the effectiveness of home-based human papilloma virus (HPV) kits to increase completion of cervical cancer screening. Compared to reminders and educational materials, mailed self-sample HPV kits increased cervical cancer screening rates by almost 15%. The results were published in JAMA, Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits. She is an investigator on a new National Cancer Institute study that is evaluating whether in clinic distribution of HPV self-testing kits or this plus mailed HPV kits increase cervical cancer screening rates compared to usual care. The study is being conducted in 42 safety net clinics in Oregon and Washington State.
Dr. Green’s previous research has shown that:
She is a member of the Target BP steering committee, an initiative to increase hypertension control that is sponsored by the American Health Association. She previously served on the steering committee of the National Colorectal Cancer Round Table (an elected position) and the U.S. Validated Blood Pressure Device Review Committee.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was an associate editor for the American Journal of Preventive Medicine from 2009 to 2014, and continues to serve on its editorial board. She is a fellow of the American Heart Association, an honor given for contributions to the field.
Dr. Green is a clinical professor at the University of Washington School of Medicine, Department of Family Medicine, and a professor at the Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science.
O'Connor EA, Nielson CM, Petrik AF, Green BB, Coronado GD Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening 2020 Feb 12;10(1):2441. doi: 10.1038/s41598-020-59032-0. Epub 2020-02-12. PubMed
Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates 2020 Feb 3;10(1):68-77. doi: 10.1093/tbm/iby094. PubMed
Coronado GD, Green BB, West II, Schwartz MR, Coury JK, Vollmer WM, Shapiro JA, Petrik AF, Baldwin LM Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study 2020 Feb;126(3):540-548. doi: 10.1002/cncr.32567. Epub 2019-10-28. PubMed
O'Connor EA, Vollmer WM, Petrik AF, Green BB, Coronado GD Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial 2020 Jan 15;21(1):91. doi: 10.1186/s13063-019-4027-7. Epub 2020-01-15. PubMed
Green BB, Baldwin LM, West II, Schwartz M, Coronado GD Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program 2020 Jan;11:2150132720958525. doi: 10.1177/2150132720958525. PubMed
Study provides economic rationale for health systems to adopt mailed kits for cervical cancer screening.
Well-timed outreach in print and video can boost awareness of repeat screening for lung cancer, study finds.
New study builds on findings that home tests improve screening rates.
Bev Green, doctor and scientist, has tips for monitoring your blood pressure without leaving your house.
AARP, June 3, 2024